Select Date
- >
Loading available days...
Available Slots:
Overview
Dr. Venkata V Sampath is a highly experienced Medical Oncologist based in Hyderabad, Telangana, with 9 years of dedicated practice in the field of oncology. He holds an impressive academic background, having earned his qualifications including DM in Medical Oncology, MD, and MBBS. Dr. Sampath exhibits a profound commitment to the well-being of his patients, applying his extensive knowledge to provide personalized and effective cancer care.
Fluent in English, Hindi, and Telugu, he is well-equipped to communicate with a diverse patient base, ensuring that all individuals have a clear understanding of their diagnosis and treatment plans. His approach is characterized by empathy and diligence, aiming to create a supportive environment for patients navigating the complexities of cancer treatment.
As part of the esteemed Apollo group, Dr. Sampath has access to advanced medical technologies and a multidisciplinary team of experts, enhancing the quality of care he provides. He is dedicated to staying updated with the latest advancements in oncology, which allows him to offer the best possible options to his patients. Dr. Sampath's patient-centric philosophy is reflected in his thorough consultations and follow-up care, where he emphasizes education and support throughout the treatment journey.
Patients seeking a compassionate and knowledgeable Medical Oncologist will find Dr. Venkata V Sampath to be an excellent choice, committed to delivering outstanding healthcare in the realm of oncology.
Experience
- Presently Working as Consultant Medical Oncology at Apollo Hospitals Jubileehills since last Assignment
- Assistant Professor, Department of Medical Oncology, SVIMS, From August 2014 to August 2015
- Consultant Oncologist at Yashoda Hospital, Secunderabad from Augus 2015
Memberships
- American Society of Medical Oncology(ASCO)
- European Society of Medical Oncology(ESMO)
- AROI
Awards
- Published research work an dcase reports in several reputed journals and presented at international conferences
PRESENTATIONS:
- Empowering patients to use tablet computer in calculating their own DAS scores; Results of a novel study. U Karjigi, et al. EULAR 2015, Rome, Italy.
- Refractory Multisystem Sarcoidosis responding to Infliximab. U Karjigi, A Paul BSR 2013, Birmingham, UK.
- Assessing the Cardiovascular risk burden in patients with RA: Role of Annual review clinic. V Patil, U Karjigi, et al EULAR 2012, Berlin, Germany.
- Acute Polymyositis associated with Haemophagocytic Lymphohistiocytosis U karjigi, M Plant Rheumatology meeting 2012, York, UK
- Multisystem Sarcoidosis involving pelvic bone responding to Infliximab U Karjigi, A Paul Rheumatology meeting 2012, York, UK
Research and Publication
Clinical Research Experience:
- Phase III, Inoperable Gastric Cancer, Sub Investigator, SVIMS/2011,
- Completed 20 Case Studies at time of M.D & D.M in NIMS & SVIMS
- A Prospective, multicenter, randomised, double blinded, 2-parallel groups, phase 3 study to compare as first line therapy efficacy and safety of masitinib in combination with gemcitabine, to gemcitabine in combination with placebo, followed as second line treatment by masitnib in combination with Folfiri 3 versus placebo in combination with Folfiri 3 in the treatment of patients with non resectable locally advanced or metastatic pancreatic cancer
- A prospective multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masatinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients with metastatic colorectal cancer
- Clinico-pathological significance of HER 2 expression in gastric cancer: A retrospective study in Indian population- JCO 2013, ASCO Vol 31, No 15-Supplymentay May 20, 2013
- Letter to editor South Asian J Cancer 2013; 2: 192
- Study of quality of life in brain tumor patients treated with three-dimensional conformal radiotherapy- JCO, 2010 ASCO Annual Meeting Proceedings( Post- Meeting Edition) Vol 28. No 15_ suppl ( May 20 supplement), 201: 2091
Special Interests
- Precision Oncology, Targeted therapy, Immuno oncology, Solid and Haematological malignancies, Breast cancer, Lung cancer, Ovarian cancer, Colon cancer, Prostate cancer, Stomach Cncer
List of Treatments
- Bad Breath Halitosis Treatment
Frequently Asked Questions
Where does Dr. Venkata Sampath V practice?
Dr. Venkata Sampath V currently practices at Apollo Health City Jubilee Hills, located in Hyderabad.
Who is Dr. Venkata Sampath V?
Dr. Venkata Sampath V is a highly experienced Medical Oncologist with 9 years of expertise in the field. He is known for providing exceptional patient care and advanced medical treatments. He areas of expertise include Bad Breath Halitosis Treatment. He also treats conditions such as , Actinic keratosis.
Why do patients choose Dr. Venkata Sampath V?
Patients trust Dr. Venkata Sampath V for he expertise, patient-centric approach, and commitment to providing the highest standard of care. He is well-versed in the latest medical advancements and ensures personalized treatment for every patient.
What is Dr. Venkata Sampath V’s specialization?
Dr. Venkata Sampath V specializes in Medical Oncology, with expertise in treatments for Bad Breath Halitosis Treatment.
What are Dr. Venkata Sampath V’s medical qualifications?
Dr. Venkata Sampath V holds prestigious qualifications, including D.M(MEDICAL ONCOLOGY), M.D(RADIATION ONCOLOGY),M.B.B.S.
How many years of experience does Dr. Venkata Sampath V have?
Dr. Venkata Sampath V has 9 years of experience in the medical field, treating various conditions related to Medical Oncology.
How can I book an appointment with Dr. Venkata Sampath V?
You can book an appointment with Dr. Venkata Sampath V through:
Online: Visit https://www.apollohospitals.com/book-doctor-appointment/ to schedule an appointment.
